Nationwide Children's News Releases
Viewing: 71-80 of 99 | All
Jun 21, 2012
Nationwide Childrens CEO to Co-Chair Parent Project Muscular Dystrophy Event
Nationwide Children’s Hospital CEO Steve Allen, MD, will serve as co-chair of the first Transforming Duchenne Care workshop to be held June 27 and 28, 2012, in Ft. Lauderdale, FL.
May 21, 2012
The 5th Annual Megans Miles Run/Walk to be Held May 27
The 5th Annual Megan’s Miles Run/Walk, benefitting Muscular Dystrophy research at Nationwide Children’s Hospital, will be held on Sunday, May 27 at noon at Central Crossing High School.
May 08, 2012
Dr. Timothy Cripe of Nationwide Childrens Hospital Appointed to a Committee of the Food and Drug Administration
Timothy Cripe, MD, PhD, chief of Hematology/Oncology/Bone Marrow Transplantation at Nationwide Children’s Hospital, was recently appointed a member of the Cellular, Tissue and Gene Therapy Advisory Committee which reports to the Food and Drug Administration (FDA).
Mar 19, 2012
Newborn Screening for Duchenne Muscular Dystrophy Shows Promise as an International Model
Investigators at Nationwide Children’s Hospital, working with the DNA Sequencing Core Facility at the University of Utah, have developed an approach to newborn screening (NBS) for the life-threatening genetic disorder, Duchenne muscular dystrophy (DMD) and potentially other muscular
Feb 29, 2012
Nationwide Childrens Hospital Neuromuscular Disorder Podcasts Now Available on iTunes
In 2010, the Center for Gene Therapy at Nationwide Children’s Hospital launched a monthly podcast entitled, “This Month in Muscular Dystrophy,” featuring internationally known scientists discussing the latest research in muscular dystrophy and other neuromuscular disorders.
Feb 22, 2012
Study: Muscle Regeneration May Provide Ideal Environment for Rhabdomyosarcoma
Inflammation, cell division and cell differentiation that occur during skeletal muscle regeneration may provide an ideal environment for the highly malignant tumor, rhabdomyosarcoma to arise.
Feb 15, 2012
Grant Provides Funding Toward Gene Therapy Clinical Trial to Replace the DMD Gene in All of the Leg Muscles of Duchenne Patients
Investigators in the Center for Gene Therapy in The Research Institute at Nationwide Children’s Hospital are working toward an approach to replace the defective gene in Duchene muscular dystrophy (DMD) by treating all of the muscles in the leg, thanks to funding from Jesse’s Journey.
Nov 02, 2011
Nationwide Children's Hospital and Ohio State Researchers Design a Viral Vector to Treat a Genetic Form of Blindness
Researchers at Ohio State University Medical Center and Nationwide Children’s Hospital have developed a viral vector designed to deliver a gene into the eyes of people born with an inherited, progressive form of blindness that affects mainly males.
Oct 03, 2011
Nationwide Childrens Hospital Researchers Receive Neurology Award for Contribution to Clinical Neuroscience
Jerry Mendell, MD, director of the Center for Gene Therapy in The Research Institute at Nationwide Children’s Hospital, and his fellow researchers, are the latest recipients of the Annals of Neurology prize for an outstanding contribution to clinical neuroscience. The study which helped Dr.
Aug 10, 2011
Human-Cell-Derived Model of ALS Provides a New Way to Study the Majority of Cases
For decades, scientists have studied a laboratory mouse model that develops signs of the paralyzing disease amyotrophic lateral sclerosis (ALS) as they age.